We initiate our own projects to stay updated with the latest CRISPR developments, continuously expanding our portfolio of services and making new reagents available.
Current projects are focused on:
- Alternative delivery systems
- FACS-based whole genome screens
- Gene editing in iPSC, in collaboration with the iPSC Center (Induced Pluripotent Stem Cells Center)
Let us know if you have suggestions or specific CRISPR requests not covered in our portfolio and we will try to help you!